JBT MAREL Corp (JBT) - 10-Q Summary for Period Ended September 30, 2024
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 30, 2024, and the nine months ended September 30, 2024. JBT provides global technology solutions to high-value segments of the food and beverage industries. The reporting period is significantly influenced by the proposed merger with Marel hf. (the "Marel Transaction"), for which a definitive agreement was signed in April 2024. The company also completed the sale of its AeroTech business in August 2023, with results from that segment classified as discontinued operations.
Key Financial Metrics
| Metric (in millions) | Q3 2024 | Q3 2023 | 9M 2024 | 9M 2023 |
|---|---|---|---|---|
| Total Revenue | $453.8 | $403.6 | $1,248.4 | $1,219.8 |
| Operating Income | $46.8 | $36.9 | $102.7 | $109.6 |
| Net Income (Continuing Ops) | $38.1 | $31.1 | $91.5 | $76.6 |
| Net Income (Total) | $38.9 | $441.6 | $92.4 | $501.5 |
| Diluted EPS (Continuing Ops) | $1.18 | $0.97 | $2.84 | $2.39 |
| Adjusted EBITDA (Continuing Ops) | $81.7 | $66.3 | $202.8 | $192.1 |
| Operating Cash Flow (9M) | $103.9 (2024) vs $95.6 (2023) | |||
| Free Cash Flow (9M) | $79.2 (2024) vs $61.8 (2023) | |||
| Cash and Equivalents | $534.5 (as of Sept 30, 2024) | |||
| Long-Term Debt | $648.3 (as of Sept 30, 2024) |
Material Changes vs. Prior Period
- Revenue Growth: Q3 2024 revenue increased 12.4% year-over-year, driven by higher pricing and volume in both recurring and non-recurring segments. Nine-month revenue grew 2.3%.
- Profitability: Operating income for Q3 rose 26.8% to $46.8 million. Gross margin improved to 36.1% in Q3 (up 20 bps) and 35.8% for the nine months (up 100 bps), aided by strategic sourcing and restructuring savings, partially offset by material cost inflation.
- Discontinued Operations: Net income comparisons are distorted by the 2023 sale of AeroTech. Q3 2023 included a $410.5 million gain from discontinued operations, whereas Q3 2024 had only $0.8 million. Excluding discontinued operations, income from continuing operations grew 22.5% in Q3.
- SG&A Expenses: Selling, general, and administrative expenses increased significantly in Q3 ($15.5 million increase) and the nine months ($37.7 million increase), primarily due to $12.9 million (Q3) and $32.6 million (9M) in M&A-related costs associated with the Marel Transaction.
- Restructuring: The 2022/2023 restructuring plan was completed as of March 31, 2024. Q3 2024 saw a net release of $0.2 million in restructuring liability, compared to $6.4 million in expense in Q3 2023.
Guidance, Outlook, and Risks
- Marel Transaction: The company expects the merger with Marel to close by the end of 2024, subject to regulatory approvals. The deal involves a mix of cash and stock consideration. JBT has secured a €1.9 billion bridge credit agreement and, in October 2024, commitments for a $1.8 billion revolving credit facility and a $900 million Term Loan B to fund the transaction.
- Outlook: Management expects full-year 2024 revenue growth driven by a strong backlog and recovery in the global poultry market. Margins are expected to improve year-over-year due to volume flow-through and cost initiatives.
- Pension Settlement: JBT plans to settle its U.S. qualified defined benefit pension plan. This will result in a non-cash pre-tax pension expense of $28 million to $32 million in Q4 2024, with the remaining accumulated loss recognized in Q1 2025 upon final settlement.
- Risks: Key risks include the potential failure or delay of the Marel Transaction, regulatory hurdles, integration challenges, and litigation related to the transaction (including a recently dismissed lawsuit regarding disclosure). Other risks include supply chain disruptions, inflation, and foreign currency fluctuations.
Investor Verification Checklist
- Marel Transaction Status: Verify the current status of regulatory approvals and the timeline for closing the Marel merger.
- Adjusted EBITDA Reconciliation: Review the specific components of the $32.6 million in M&A costs included in the nine-month Adjusted EBITDA calculation.
- Pension Impact: Confirm the timing and magnitude of the non-cash pension expense expected in Q4 2024 and Q1 2025.
- Debt Structure: Analyze the terms of the new $1.8 billion revolving credit facility and $900 million Term Loan B secured in October 2024, including interest rates and covenants.
- Backlog Visibility: Assess the $698.1 million in remaining performance obligations and the expected recognition timeline (48% in 2024, 49% in 2025).